Oxidative Stress Reduction Related To The Efficacy Of N-3 Polyunsaturated Fatty Acids In First Episode Schizophrenia: Secondary Outcome Analysis Of The OFFER Randomized Trial
Notes for this study:
||Difference between treatment and olive oil placebo group: -0.17 ng/mL (95% CI: -0.25 to -0.08)
|Number of Subjects
This is a secondary analysis of a previous study in people with schizophrenia looking at the effect of 1320 mg EPA + 880 mg DHA daily on symptoms of schizophrenia and affect. This particular secondary analysis focused on the impact on markers of oxidative stress.
Funding issues for this study: